CTB news banner

Breadcrumb

Asset Publisher

Anti-TB drugs can increase risk of TB re-infection

Treatment leads to changes in gut microbiota, compromising immunity

Using laser light to study how epilepsy arises in the healthy brain

Scientists at the RI-MUHC have developed a new method to study how seizures arise in the healthy brain.

RI-MUHC researcher to receive new funding from GlycoNet

Dr. Don Sheppard`s project in collaboration with The Hospital for Sick Children aims to improve the health of Canadians while generating positive economic outcomes

Three RI-MUHC teams receive funding from the CFI and Government of Quebec

Funding will “provide our researchers with the foundational infrastructure needed to become leading-edge contributors in diverse research fields,” says Martha Crago

A second case of HIV remission

RI-MUHC researchers consulted on implications for HIV research

International team of scientists detect cause of rare pediatric brain disorder

RI-MUHC pediatric researcher joins efforts with scientists from the Rady Children’s Institute for Genomic Medicine to discover new mutation

Viral communications hacking boosts Leishmania infections

New study sheds light on viral biology, could lead to efficient vaccines against a tropical disease

Shared genetic marker offers new promise in targeting specific ovarian and lung cancers

Two new papers offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer

A hide-out for viruses in the testicles

RI-MUHC team leads an innovative study using testicular tissue to unlock the secrets of the immune system...

Quebec researchers among recipients of $34 million “Grand Challenge” Grant from Cancer Research UK to combat cancer

Research teams from McGill and MUHC are part of an international effort to uncover how chronic inflammation causes cancer

Confronting a killer

Defeating tuberculosis (TB) will require in-depth collaboration, including researchers, medical professionals but also the communities...

Heart & Stroke honours RI-MUHC researcher

On November 14, the Heart and Stroke Foundation honoured three researchers – including two McGill faculty members – with an award...

Innovative biosensor technology reveals secrets of how drugs work

What if we could take advantage of a drug’s benefit without side effects? Stéphane Laporte, PhD is conducting research in his laboratory at the Glen...

RI-MUHC scientist receives Terry Fox funding to study metastatic sarcomas

As Terry Fox approached the city of Thunder Bay in Ontario on Sept. 1, 1980, a strange pain took hold of his chest. The 22-year-old had been...

How does cancer spread?

How does cancer spread? While studying human brain tumour cells, a team of scientists at the Research Institute of the McGill University...

Another Medical Cold Case Cracked by the MUHC’s ‘Dr. House’

A team from the Research Institute of the McGill University Health Centre (RI-MUHC) led by Dr. Donald Vinh, the RI-MUHC’s so-called...

Scientists identify new genetic causes linked to abnormal pregnancies and miscarriages

A team of scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University have identified...

Can't sleep? Fruit flies and energy drinks offer new clues

Sleep is an essential behavioural state in animals ranging from invertebrates to humans. It is critical for immune function, stable metabolism...

Eva Kaufmann receives award from the German Society for Immunology

Eva Kaufmann, DVM, PhD, a postdoctoral student in the lab of Maziar Divangahi, PhD, at the Research Institute of the McGill University Health...

Scientific breakthrough: promising new target for immunotherapy

Following the 2018 Nobel Prize for Medicine, global attention is now more than ever turned toward the promise of...

See Archive - CTB News